ID

20334

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Keywords

Versions (2)
  1. 2/15/17 2/15/17 -
  2. 2/20/17 2/20/17 -
Uploaded on

February 20, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

English

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 forms  
Inclusion Exclusion Criteria
Description

Inclusion Exclusion Criteria

Alias
UMLS CUI-1
C1512693
UMLS CUI-3
C0680251
Did the subject meet all the entry criteria at the time of enrollment (see opposite page)
Description

Entry criteria

Data type

boolean

Alias
UMLS CUI [1]
C1516637
If no, please give line number(s) of the corresponding criteria not met
Description

Numbers of the corresponding criteria

Data type

text

Randomisation
Description

Randomisation

Alias
UMLS CUI-1
C0034656
Date of randomisation using IVRS (dd mon yy)
Description

Date of randomisation

Data type

date

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0011008
Trial Drug Administration
Description

Trial Drug Administration

Alias
UMLS CUI-1
C3469597
Will the trial medication kit be dispensed to the patient?
Description

Trial medication kit

Data type

boolean

Alias
UMLS CUI [1]
C0013227
If YES, provide patient with trial medication kit assigned by IVRS. Stick the label from trial medication kit below. If label is lost, please enter assigned medication number below:
Description

If yes

Data type

text

Alias
UMLS CUI [1]
C2360065
UMLS CUI [2]
C1521902
If NO, primary reason for not dispensing trial drug (indicate one)
Description

If NO

Data type

integer

Alias
UMLS CUI [1]
C1521902
Explain other:
Description

Other

Data type

text

Alias
UMLS CUI [1]
C1521902
Preparation For Next Visit
Description

Preparation For Next Visit

Alias
UMLS CUI-1
C1521827
UMLS CUI-2
C1522577
Investigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.
Description

Investigator´s Declaration

Data type

text

Signature by investigator
Description

Signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Date (dd mon yy)
Description

Investigator Signature Date

Data type

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Back to the top of the page

Similar models

Inclusion Exclusion Randomization Trial Drug Administration PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Exclusion Criteria
C1512693 (UMLS CUI-1)
C0680251 (UMLS CUI-3)
Entry criteria
Item
Did the subject meet all the entry criteria at the time of enrollment (see opposite page)
boolean
C1516637 (UMLS CUI [1])
Numbers of the corresponding criteria
Item
If no, please give line number(s) of the corresponding criteria not met
text
Item Group
Randomisation
C0034656 (UMLS CUI-1)
Date of randomisation
Item
Date of randomisation using IVRS (dd mon yy)
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Trial Drug Administration
C3469597 (UMLS CUI-1)
Trial medication kit
Item
Will the trial medication kit be dispensed to the patient?
boolean
C0013227 (UMLS CUI [1])
If yes
Item
If YES, provide patient with trial medication kit assigned by IVRS. Stick the label from trial medication kit below. If label is lost, please enter assigned medication number below:
text
C2360065 (UMLS CUI [1])
C1521902 (UMLS CUI [2])
Item
If NO, primary reason for not dispensing trial drug (indicate one)
integer
C1521902 (UMLS CUI [1])
If NO
Code List
If NO, primary reason for not dispensing trial drug (indicate one)
CL Item
Adverse event (1)
CL Item
Inclusion / Exclusion criteria not met (2)
CL Item
Lost follow-up (3)
CL Item
Consent withdrawn (not due to adverse event) (4)
CL Item
Other (explain below) (5)
Other
Item
Explain other:
text
C1521902 (UMLS CUI [1])
Item Group
Preparation For Next Visit
C1521827 (UMLS CUI-1)
C1522577 (UMLS CUI-2)
Investigator´s Declaration
Item
Investigator´s Declaration By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.
text
Signature
Item
Signature by investigator
text
C2346576 (UMLS CUI [1])
Investigator Signature Date
Item
Date (dd mon yy)
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial